Effectiveness and safety of silodosin in the treatment of LUTS in patients with benign prostatic hyperplasia: a European phase IV clinical study (the Silodosin in Real-life Evaluation study)

Trial Profile

Effectiveness and safety of silodosin in the treatment of LUTS in patients with benign prostatic hyperplasia: a European phase IV clinical study (the Silodosin in Real-life Evaluation study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Aug 2016

At a glance

  • Drugs Silodosin (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Acronyms SIRE
  • Sponsors Recordati
  • Most Recent Events

    • 15 Apr 2014 Results presented at the 29th Congress of the European Association of Urology.
    • 02 Jan 2013 Planned end date changed from 17 Nov 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.
    • 02 Jan 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01757769).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top